Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

10% hPL is best for growing mesenchymal stem cells, while 10% FBS is best for hepatocytes.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

People with alopecia areata are more likely to have major depression, possibly linked to a specific genetic region.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Store stem cells at 4°C in 10% human serum and use within 2-4 hours for best results.

CD146 + mesenchymal stem cells are more effective for treating premature ovarian failure.

Enhanced stem cells from the placenta can help treat Graves' eye disease by stopping fat cell growth.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

Tofacitinib helped regrow hair in a woman with alopecia areata.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Encapsulated stem cell exosomes in hydrogel improve wound healing.

Wharton's jelly stem cells show diverse traits and functions.

Mesenchymal stem cell therapy shows promise for liver disease but faces challenges in standardization and approval.

Stem cell vesicles can reduce skin aging from UVB by lowering inflammation and oxidative stress.

Sulfasalazine may help regrow hair in severe alopecia areata cases.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

The combination of stem cell medium and hydrogel effectively reduces and improves hypertrophic scars.